Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 43 entries
Sorted by: Best Match Show Resources per page
Surfactant-triggered disassembly of electrostatic complexes probed at optical and quartz crystal microbalance length scales.

Langmuir : the ACS journal of surfaces and colloids

Schonbeck N, Kvale K, Demarcy T, Giermanska J, Chapel JP, Berret JF.
PMID: 24773519
Langmuir. 2014 May 20;30(19):5620-7. doi: 10.1021/la500948h. Epub 2014 May 06.

A critical advantage of electrostatic assemblies over covalent and crystalline bound materials is that associated structures can be disassembled into their original constituents. Nanoscale devices designed for the controlled release of functional molecules already exploit this property. To bring...

Cite
Schonbeck N, Kvale K, Demarcy T, et al. Surfactant-triggered disassembly of electrostatic complexes probed at optical and quartz crystal microbalance length scales. Langmuir. 2014;30(19):5620-7doi: 10.1021/la500948h.
Schonbeck, N., Kvale, K., Demarcy, T., Giermanska, J., Chapel, J. P., & Berret, J. F. (2014). Surfactant-triggered disassembly of electrostatic complexes probed at optical and quartz crystal microbalance length scales. Langmuir : the ACS journal of surfaces and colloids, 30(19), 5620-7. https://doi.org/10.1021/la500948h
Schonbeck, N, et al. "Surfactant-triggered disassembly of electrostatic complexes probed at optical and quartz crystal microbalance length scales." Langmuir : the ACS journal of surfaces and colloids vol. 30,19 (2014): 5620-7. doi: https://doi.org/10.1021/la500948h
Schonbeck N, Kvale K, Demarcy T, Giermanska J, Chapel JP, Berret JF. Surfactant-triggered disassembly of electrostatic complexes probed at optical and quartz crystal microbalance length scales. Langmuir. 2014 May 20;30(19):5620-7. doi: 10.1021/la500948h. Epub 2014 May 06. PMID: 24773519.
Copy Download .nbib Format: NLM
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma.

Oncology letters

Saif MW, Ledbetter L, Kaley K, Garcon MC, Rodriguez T, Syrigos KN.
PMID: 25120712
Oncol Lett. 2014 Sep;8(3):1302-1306. doi: 10.3892/ol.2014.2238. Epub 2014 Jun 11.

Therapeutic options for locally advanced pancreatic cancer (LAPC) include concurrent chemoradiation, induction chemotherapy followed by chemoradiation or systemic therapy alone. The original Gastro-Intestinal Study Group and Eastern Cooperative Oncology Group studies defined fluorouracil (5-FU) with concurrent radiation therapy followed...

Cite
Saif MW, Ledbetter L, Kaley K, et al. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncol Lett. 2014;8(3):1302-1306doi: 10.3892/ol.2014.2238.
Saif, M. W., Ledbetter, L., Kaley, K., Garcon, M. C., Rodriguez, T., & Syrigos, K. N. (2014). Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncology letters, 8(3), 1302-1306. https://doi.org/10.3892/ol.2014.2238
Saif, Muhammad Wasif, et al. "Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma." Oncology letters vol. 8,3 (2014): 1302-1306. doi: https://doi.org/10.3892/ol.2014.2238
Saif MW, Ledbetter L, Kaley K, Garcon MC, Rodriguez T, Syrigos KN. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Oncol Lett. 2014 Sep;8(3):1302-1306. doi: 10.3892/ol.2014.2238. Epub 2014 Jun 11. PMID: 25120712; PMCID: PMC4114599.
Copy Download .nbib Format: NLM
Being Normal Weight but Feeling Overweight in Adolescence May Affect Weight Development into Young Adulthood-An 11-Year Followup: The HUNT Study, Norway.

Journal of obesity

Cuypers K, Kvaløy K, Bratberg G, Midthjell K, Holmen J, Holmen TL.
PMID: 22666556
J Obes. 2012;2012:601872. doi: 10.1155/2012/601872. Epub 2012 May 16.

Objectives. To explore if self-perceived overweight in normal weight adolescents influence their weight development into young adulthood and if so, whether physical activity moderates this association. Methods. A longitudinal study of 1196 normal weight adolescents (13-19 yrs) who were...

Cite
Cuypers K, Kvaløy K, Bratberg G, et al. Being Normal Weight but Feeling Overweight in Adolescence May Affect Weight Development into Young Adulthood-An 11-Year Followup: The HUNT Study, Norway. J Obes. 2012;2012:601872doi: 10.1155/2012/601872.
Cuypers, K., Kvaløy, K., Bratberg, G., Midthjell, K., Holmen, J., & Holmen, T. L. (2012). Being Normal Weight but Feeling Overweight in Adolescence May Affect Weight Development into Young Adulthood-An 11-Year Followup: The HUNT Study, Norway. Journal of obesity, 2012601872. https://doi.org/10.1155/2012/601872
Cuypers, Koenraad, et al. "Being Normal Weight but Feeling Overweight in Adolescence May Affect Weight Development into Young Adulthood-An 11-Year Followup: The HUNT Study, Norway." Journal of obesity vol. 2012 (2012): 601872. doi: https://doi.org/10.1155/2012/601872
Cuypers K, Kvaløy K, Bratberg G, Midthjell K, Holmen J, Holmen TL. Being Normal Weight but Feeling Overweight in Adolescence May Affect Weight Development into Young Adulthood-An 11-Year Followup: The HUNT Study, Norway. J Obes. 2012;2012:601872. doi: 10.1155/2012/601872. Epub 2012 May 16. PMID: 22666556; PMCID: PMC3362140.
Copy Download .nbib Format: NLM
Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy.

Case reports in medicine

Saif MW, Galanina N, Ravage-Mass L, Kaley K, Cornfeld D, Lamb L, Chhieng D.
PMID: 20862374
Case Rep Med. 2010;2010. doi: 10.1155/2010/634975. Epub 2010 Aug 24.

Pancreatic cancer remains a challenge both diagnostically and therapeutically. The typical sites of metastases in pancreatic cancer include the liver and peritoneum. Other less common sites are the lung, brain, kidney, and bone. Skeletal metastases are less prevalent in...

Cite
Saif MW, Galanina N, Ravage-Mass L, et al. Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy. Case Rep Med. 2010;2010doi: 10.1155/2010/634975.
Saif, M. W., Galanina, N., Ravage-Mass, L., Kaley, K., Cornfeld, D., Lamb, L., & Chhieng, D. (2010). Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy. Case reports in medicine, 2010. https://doi.org/10.1155/2010/634975
Saif, Muhammad Wasif, et al. "Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy." Case reports in medicine vol. 2010 (2010). doi: https://doi.org/10.1155/2010/634975
Saif MW, Galanina N, Ravage-Mass L, Kaley K, Cornfeld D, Lamb L, Chhieng D. Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy. Case Rep Med. 2010;2010. doi: 10.1155/2010/634975. Epub 2010 Aug 24. PMID: 20862374; PMCID: PMC2938458.
Copy Download .nbib Format: NLM
Extraosseous Ewing's Sarcoma of the Pancreas: An Uncommon but Treatable Disease.

Cureus

Saif MW, Kaley K.
PMID: 29387511
Cureus. 2017 Nov 26;9(11):e1882. doi: 10.7759/cureus.1882.

Extraosseous Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) is a rare but aggressive and malignant tumor, and has been reported in various sites such as the lungs, biliary tract, kidney, prostate, stomach, esophagus, oral cavity, salivary glands, urinary bladder, uterus, cervix,...

Cite
Saif MW, Kaley K. Extraosseous Ewing's Sarcoma of the Pancreas: An Uncommon but Treatable Disease. Cureus. 2017;9(11):e1882doi: 10.7759/cureus.1882.
Saif, M. W., & Kaley, K. (2017). Extraosseous Ewing's Sarcoma of the Pancreas: An Uncommon but Treatable Disease. Cureus, 9(11), e1882. https://doi.org/10.7759/cureus.1882
Saif, Muhammad W, and Kaley, Kristin. "Extraosseous Ewing's Sarcoma of the Pancreas: An Uncommon but Treatable Disease." Cureus vol. 9,11 (2017): e1882. doi: https://doi.org/10.7759/cureus.1882
Saif MW, Kaley K. Extraosseous Ewing's Sarcoma of the Pancreas: An Uncommon but Treatable Disease. Cureus. 2017 Nov 26;9(11):e1882. doi: 10.7759/cureus.1882. PMID: 29387511; PMCID: PMC5786351.
Copy Download .nbib Format: NLM
Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease.

JGH open : an open access journal of gastroenterology and hepatology

Carlsen A, Omdal R, Karlsen L, Kvaløy JT, Aabakken L, Steinsbø Ø, Bolstad N, Warren D, Lundin KEA, Grimstad T.
PMID: 32514446
JGH Open. 2019 Oct 06;4(3):410-416. doi: 10.1002/jgh3.12266. eCollection 2020 Jun.

BACKGROUND AND AIM: Adalimumab is administered and dosed using a standardized treatment regimen. Although therapeutic drug monitoring (TDM) may help optimize treatment efficacy, the lower cut-off concentration of adalimumab needed to retain disease remission has not been established. This...

Cite
Carlsen A, Omdal R, Karlsen L, et al. Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease. JGH Open. 2019;4(3):410-416doi: 10.1002/jgh3.12266.
Carlsen, A., Omdal, R., Karlsen, L., Kvaløy, J. T., Aabakken, L., Steinsbø, �. �., Bolstad, N., Warren, D., Lundin, K. E. A., & Grimstad, T. (2020). Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease. JGH open : an open access journal of gastroenterology and hepatology, 4(3), 410-416. https://doi.org/10.1002/jgh3.12266
Carlsen, Arne, et al. "Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease." JGH open : an open access journal of gastroenterology and hepatology vol. 4,3 (2020): 410-416. doi: https://doi.org/10.1002/jgh3.12266
Carlsen A, Omdal R, Karlsen L, Kvaløy JT, Aabakken L, Steinsbø Ø, Bolstad N, Warren D, Lundin KEA, Grimstad T. Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease. JGH Open. 2019 Oct 06;4(3):410-416. doi: 10.1002/jgh3.12266. eCollection 2020 Jun. PMID: 32514446; PMCID: PMC7273736.
Copy Download .nbib Format: NLM
Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer.

Cureus

Suzukida J, Kaley K, Raza A, Saif MW.
PMID: 27555985
Cureus. 2016 Jul 13;8(7):e687. doi: 10.7759/cureus.687.

Pancreatic cancer remains a diagnosis of poor prognosis with a median survival time of four-six months in patients with advanced stage of the disease. Although, with the development of novel chemotherapy agents some patients are able to live a...

Cite
Suzukida J, Kaley K, Raza A, et al. Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer. Cureus. 2016;8(7):e687doi: 10.7759/cureus.687.
Suzukida, J., Kaley, K., Raza, A., & Saif, M. W. (2016). Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer. Cureus, 8(7), e687. https://doi.org/10.7759/cureus.687
Suzukida, Jillian, et al. "Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer." Cureus vol. 8,7 (2016): e687. doi: https://doi.org/10.7759/cureus.687
Suzukida J, Kaley K, Raza A, Saif MW. Therapy-Associated Myeloid Dysplasia in a Long-Surviving Patient with Pancreatic Cancer. Cureus. 2016 Jul 13;8(7):e687. doi: 10.7759/cureus.687. PMID: 27555985; PMCID: PMC4981410.
Copy Download .nbib Format: NLM
Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension.

Cureus

Saif MW, Kaley K, Lamb L.
PMID: 27555987
Cureus. 2016 Jul 14;8(7):e689. doi: 10.7759/cureus.689.

Pancreatic cancer is known for vague symptoms that lead to a delay in diagnosis, and hence most cases are found at an advanced stage. Many complications can happen secondary to pancreatic cancer including diabetes, malabsorption, and deep venous thrombosis....

Cite
Saif MW, Kaley K, Lamb L. Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension. Cureus. 2016;8(7):e689doi: 10.7759/cureus.689.
Saif, M. W., Kaley, K., & Lamb, L. (2016). Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension. Cureus, 8(7), e689. https://doi.org/10.7759/cureus.689
Saif, Muhammad W, et al. "Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension." Cureus vol. 8,7 (2016): e689. doi: https://doi.org/10.7759/cureus.689
Saif MW, Kaley K, Lamb L. Pancreatic Adenocarcinoma Complicated by Sinistral Portal Hypertension. Cureus. 2016 Jul 14;8(7):e689. doi: 10.7759/cureus.689. PMID: 27555987; PMCID: PMC4980218.
Copy Download .nbib Format: NLM
Exercise training increases protein O-GlcNAcylation in rat skeletal muscle.

Physiological reports

Hortemo KH, Lunde PK, Anonsen JH, Kvaløy H, Munkvik M, Rehn TA, Sjaastad I, Lunde IG, Aronsen JM, Sejersted OM.
PMID: 27664189
Physiol Rep. 2016 Sep;4(18). doi: 10.14814/phy2.12896.

Protein O-GlcNAcylation has emerged as an important intracellular signaling system with both physiological and pathophysiological functions, but the role of protein O-GlcNAcylation in skeletal muscle remains elusive. In this study, we tested the hypothesis that protein O-GlcNAcylation is a...

Cite
Hortemo KH, Lunde PK, Anonsen JH, et al. Exercise training increases protein O-GlcNAcylation in rat skeletal muscle. Physiol Rep. 2016;4(18)doi: 10.14814/phy2.12896.
Hortemo, K. H., Lunde, P. K., Anonsen, J. H., Kvaløy, H., Munkvik, M., Rehn, T. A., Sjaastad, I., Lunde, I. G., Aronsen, J. M., & Sejersted, O. M. (2016). Exercise training increases protein O-GlcNAcylation in rat skeletal muscle. Physiological reports, 4(18), . https://doi.org/10.14814/phy2.12896
Hortemo, Kristin Halvorsen, et al. "Exercise training increases protein O-GlcNAcylation in rat skeletal muscle." Physiological reports vol. 4,18 (2016). doi: https://doi.org/10.14814/phy2.12896
Hortemo KH, Lunde PK, Anonsen JH, Kvaløy H, Munkvik M, Rehn TA, Sjaastad I, Lunde IG, Aronsen JM, Sejersted OM. Exercise training increases protein O-GlcNAcylation in rat skeletal muscle. Physiol Rep. 2016 Sep;4(18). doi: 10.14814/phy2.12896. PMID: 27664189; PMCID: PMC5037911.
Copy Download .nbib Format: NLM
Draft Genome Sequence of Strain CBD-635, a Methicillin-Resistant Staphylococcus aureus USA100 Isolate.

Genome announcements

Carroll RK, Burda WN, Roberts JC, Peak KK, Cannons AC, Shaw LN.
PMID: 23846279
Genome Announc. 2013 Jul 11;1(4). doi: 10.1128/genomeA.00491-13.

We present the draft genome sequence of methicillin-resistant Staphylococcus aureus strain CBD-635, from the USA100 lineage. This is a sepsis isolate obtained from Tampa General Hospital. This strain is spa type t003 and multilocus sequence typing (MLST) type ST5,...

Cite
Carroll RK, Burda WN, Roberts JC, et al. Draft Genome Sequence of Strain CBD-635, a Methicillin-Resistant Staphylococcus aureus USA100 Isolate. Genome Announc. 2013;1(4)doi: 10.1128/genomeA.00491-13.
Carroll, R. K., Burda, W. N., Roberts, J. C., Peak, K. K., Cannons, A. C., & Shaw, L. N. (2013). Draft Genome Sequence of Strain CBD-635, a Methicillin-Resistant Staphylococcus aureus USA100 Isolate. Genome announcements, 1(4), . https://doi.org/10.1128/genomeA.00491-13
Carroll, Ronan K, et al. "Draft Genome Sequence of Strain CBD-635, a Methicillin-Resistant Staphylococcus aureus USA100 Isolate." Genome announcements vol. 1,4 (2013). doi: https://doi.org/10.1128/genomeA.00491-13
Carroll RK, Burda WN, Roberts JC, Peak KK, Cannons AC, Shaw LN. Draft Genome Sequence of Strain CBD-635, a Methicillin-Resistant Staphylococcus aureus USA100 Isolate. Genome Announc. 2013 Jul 11;1(4). doi: 10.1128/genomeA.00491-13. PMID: 23846279; PMCID: PMC3709156.
Copy Download .nbib Format: NLM
Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.

BMC cardiovascular disorders

Michalsen VL, Wild SH, Kvaløy K, Svartberg J, Melhus M, Broderstad AR.
PMID: 34674643
BMC Cardiovasc Disord. 2021 Oct 21;21(1):510. doi: 10.1186/s12872-021-02288-9.

BACKGROUND: The mortality of metabolic-obesity phenotypes has been thoroughly studied, but it is not known if or how the association between mortality and body mass index (BMI), waist circumference or a body shape index (ABSI) differ in strata of...

Cite
Michalsen VL, Wild SH, Kvaløy K, et al. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study. BMC Cardiovasc Disord. 2021;21(1):510doi: 10.1186/s12872-021-02288-9.
Michalsen, V. L., Wild, S. H., Kvaløy, K., Svartberg, J., Melhus, M., & Broderstad, A. R. (2021). Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study. BMC cardiovascular disorders, 21(1), 510. https://doi.org/10.1186/s12872-021-02288-9
Michalsen, Vilde Lehne, et al. "Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study." BMC cardiovascular disorders vol. 21,1 (2021): 510. doi: https://doi.org/10.1186/s12872-021-02288-9
Michalsen VL, Wild SH, Kvaløy K, Svartberg J, Melhus M, Broderstad AR. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study. BMC Cardiovasc Disord. 2021 Oct 21;21(1):510. doi: 10.1186/s12872-021-02288-9. PMID: 34674643; PMCID: PMC8529837.
Copy Download .nbib Format: NLM
The .

Frontiers in microbiology

Grøsvik K, Tesfahun AN, Muruzábal-Lecumberri I, Haugland GT, Leiros I, Ruoff P, Kvaløy JT, Knævelsrud I, Ånensen H, Alexeeva M, Sato K, Matsuda A, Alseth I, Klungland A, Bjelland S.
PMID: 32158436
Front Microbiol. 2020 Feb 25;11:263. doi: 10.3389/fmicb.2020.00263. eCollection 2020.

The cellular methyl donor

Cite
Grøsvik K, Tesfahun AN, Muruzábal-Lecumberri I, et al. The . Front Microbiol. 2020;11:263doi: 10.3389/fmicb.2020.00263.
Grøsvik, K., Tesfahun, A. N., Muruzábal-Lecumberri, I., Haugland, G. T., Leiros, I., Ruoff, P., Kvaløy, J. T., Knævelsrud, I., Ånensen, H., Alexeeva, M., Sato, K., Matsuda, A., Alseth, I., Klungland, A., & Bjelland, S. (2020). The . Frontiers in microbiology, 11263. https://doi.org/10.3389/fmicb.2020.00263
Grøsvik, Kristin, et al. "The ." Frontiers in microbiology vol. 11 (2020): 263. doi: https://doi.org/10.3389/fmicb.2020.00263
Grøsvik K, Tesfahun AN, Muruzábal-Lecumberri I, Haugland GT, Leiros I, Ruoff P, Kvaløy JT, Knævelsrud I, Ånensen H, Alexeeva M, Sato K, Matsuda A, Alseth I, Klungland A, Bjelland S. The . Front Microbiol. 2020 Feb 25;11:263. doi: 10.3389/fmicb.2020.00263. eCollection 2020. PMID: 32158436; PMCID: PMC7051996.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 43 entries